Strides Pharma Science Limited Stock price

Equities

STAR

INE939A01011

Pharmaceuticals

Delayed NSE India S.E. 03:04:56 22/02/2024 pm IST 5-day change 1st Jan Change
808 INR -2.67% Intraday chart for Strides Pharma Science Limited -0.61% +24.48%
Sales 2024 * 41.51B 501M Sales 2025 * 45.77B 552M Capitalization 76.29B 920M
Net income 2024 * -414M -4.99M Net income 2025 * 2.92B 35.24M EV / Sales 2024 * 1.84 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.67 x
P/E ratio 2024 *
-180 x
P/E ratio 2025 *
20.5 x
Employees 2,850
Yield 2024 *
0.43%
Yield 2025 *
0.43%
Free-Float 68.57%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.64%
1 week-0.61%
Current month+15.67%
1 month+23.78%
3 months+66.01%
6 months+93.79%
Current year+24.48%
More quotes
1 week
800.10
Extreme 800.1
838.60
1 month
643.80
Extreme 643.8
838.60
Current year
643.80
Extreme 643.8
838.60
1 year
268.15
Extreme 268.15
838.60
3 years
263.35
Extreme 263.35
947.00
5 years
263.35
Extreme 263.35
999.00
10 years
263.35
Extreme 263.35
1 414.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 28/90/28
Director of Finance/CFO - 01/10/01
Compliance Officer - 03/17/03
Members of the board TitleAgeSince
Chief Executive Officer 63 28/90/28
Director/Board Member 80 18/17/18
Director/Board Member 63 27/12/27
More insiders
Date Price Change Volume
22/24/22 808 -2.67% 258 772
21/24/21 830.1 +1.21% 397,067
20/24/20 820.2 -1.83% 247,314
19/24/19 835.4 +2.61% 554,618
16/24/16 814.2 +0.12% 477,711

Delayed Quote NSE India S.E., February 22, 2024 at 03:04 pm IST

More quotes
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche and pharmaceutical products. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
830.1 INR
Average target price
801.5 INR
Spread / Average Target
-3.45%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Strides Pharma Science Limited - NSE India S.E.
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer